In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K

In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K

Posted by Corey Marcath on

Single Donor Human Red Blood Cells from Innovative Research was used in the following study:

 

In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K

Sven-Ulrik Gorr, Craig M. Flory, Robert J. Schumacher

PLOS ONE
May 9, 2019

“…Traditional antibiotics are losing their effectiveness due to increasing bacterial resistance. Combined with a decreasing pipeline of novel drugs, it is feared that many critical infections will be difficult or impossible to treat in the near future. …Human red blood cells (RBC) (single donor) were obtained from Innovative Research (Novi, MI)…”

 

Related products available from Innovative Research also include:

  • Tags: Human Whole Blood, Single Donor Human Red Blood Cells

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS
    Pooled Human Plasma Apheresis Derived from Innovative Research was used in the followin...
    Read the Article
    Reactive Olfaction Ambient Mass Spectrometry
    Single Donor Human Urine from Innovative Research was used in the following study:   R...
    Read the Article

    ← Older Post Newer Post →